The latest issue of Cabot Marijuana Investor is now available, with my current advice on the sixteen stocks in the portfolio.
The gains so far this year, in both the sector and the portfolio, have been absolutely spectacular, but they won’t continue. Already I detect signs of a rolling correction and there’s the possibility that short-term, it could get worse. So in this issue, I have some sell recommendations, for investors who are working to develop maximum gains.
For longer-term, more patient investors, however, doing nothing is fine. The long-term prospects for both the industry and the sector remain bright.